Blog
RSS FeedPosted by Michael Wonder on 13 Feb 2020
The grass is the same colour, part II: prescription drug woes on both sides of the US-Canada border
13 February 2020 - Which industrialised nation with a fractured health care system and a divided government is having a high-stakes ...
Posted by Michael Wonder on 12 Feb 2020
Quebec, New Brunswick, Newfoundland, Nova Scotia and Manitoba join Alberta, Saskatchewan, in adding Knight’s Probuphine to their provincial drug plans in the fight against the opioid crisis
11 February 2020 - Probuphine is also listed for reimbursement through the Non-Insured Health Benefit (NIHB) and Veteran Affairs Canada drug ...
Posted by Michael Wonder on 09 Feb 2020
N.S. senior blasts province over blood thinner coverage under pharmacare
6 February 2020 - Province covers warfarin, but it requires closer monitoring than newer, more expensive alternative, apixaban. ...
Posted by Michael Wonder on 09 Feb 2020
Extreme regulations to lower drug prices mean Canada will get fewer new drugs
7 February 2020 - Severe price cuts would clearly discourage pharmaceutical manufacturers from launching new drugs in Canada. ...
Posted by Michael Wonder on 07 Feb 2020
AbbVie's Skyrizi now publicly reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the treatment of moderate to severe plaque psoriasis
6 February 2020 - Skyrizi is the only IL-23 inhibitor to arrive at a positive conclusion with the pCPA and is ...
Posted by Michael Wonder on 05 Feb 2020
Pharma execs argue new Canadian regulations for setting drug prices will hurt the country
4 February 2020 - As Canada gets set to implement new regulations designed to cut prescription drug spending, the pharmaceutical ...
Posted by Michael Wonder on 31 Jan 2020
When a lottery 'wins' sick babies life-saving drugs
30 January 2020 - Eva was diagnosed with spinal muscular atrophy, a motor neuron disease, just a few weeks after ...
Posted by Michael Wonder on 30 Jan 2020
The life-saving medicine she needs is cheap, common and unavailable in Canadian pharmacies
30 January 2020 - Cassidy Armstrong among a fewer than 200 Canadians who must apply for access. ...
Posted by Michael Wonder on 29 Jan 2020
B.C. eye-injection program ‘clouded in secrecy’
28 January 2020 - Two dozen ophthalmologists are accusing the B.C. government of failing to properly investigate concerns that a ...
Posted by Michael Wonder on 26 Jan 2020
Pickering, Ont. mother living with cystic fibrosis approved for miracle drug: ‘I’m in shock’
24 January 2020 - A Pickering, Ont. mother fighting cystic fibrosis has received her late Christmas wish. ...
Posted by Michael Wonder on 22 Jan 2020
Morneau says Ottawa will need to work with provinces on issues like universal pharmacare
19 January 2020 - Finance Minister Bill Morneau said that the federal government will often need to work together with provinces ...
Posted by Michael Wonder on 22 Jan 2020
Amazon just filed a bunch of international trademarks for ‘Amazon Pharmacy’
21 January 2020 - Amazon bought an Internet pharmacy business called PillPack in 2018. ...
Posted by Michael Wonder on 19 Jan 2020
Is innovation causing accessibility, timing issues for private drug plans?
17 January 2020 - Pharmaceutical companies and private payers can interact in different ways to ensure the right drugs are ...
Posted by Michael Wonder on 16 Jan 2020
Why Canada won't end up as the drugstore to the U.S.
16 January 2020 - Although in theory the new U.S. import proposals could significantly affect Canadians and their drug supplies, their ...
Posted by Michael Wonder on 14 Jan 2020
B.C. funding decision on pricey drug leaves teen with rare disease facing 'scary' future
13 January 2020 - Miles Ambridge just misses cut-off age to access Spinraza, a potentially life-changing treatment. ...